Progress Toward A Vaccine To Fight Cocaine Addiction
Is Reported
8-25-1999
NEW ORLEANS, La., -- A potential vaccine against the
addictive effects of cocaine was described here today
at the national meeting of the American Chemical Society,
the world's largest scientific society.
Kim
D. Janda, Ph.D., a scientist at The Scripps Research
Institute, La Jolla, Calif., said he has induced the
immune system to create specific antibodies that attack
the cocaine molecule and keep it from reaching its target,
the central nervous system.
Cocaine
does not produce antibodies because its molecule is
too small to be recognized by the immune system. Janda
said he has overcome this obstacle by attaching a cocaine
derivative to a larger protein, an effect he calls "painting
a bulls-eye" on the derivative. Over a period of
several weeks, the body builds up a sufficient amount
of cocaine antibodies to create an effective vaccine
in a process called "active immunization."
Using laboratory cloning techniques, Janda's research
team has also created an antibody which, when injected
in large quantities, reduces the toxic effects of cocaine
overdose.
Janda
said animal studies are in the final stages of completion
and human clinical trials should begin by the end of
the year.